Torrent Pharmaceuticals Limited — Board Meeting, 28-07-2025: Outcome of Board Meeting

Torrent Pharma has announced a board meeting today, where it approved the financial results for the quarter. The company reported robust Q1 FY26 consolidated results, with revenue growing 11% year-on-year to ₹3,178 Cr. Net profit surged 20% to ₹548 Cr. The Board also approved raising funds by issuing Non-Convertible Debentures via private placement. A significant strategic update is the planned two-phase acquisition of J.B. Chemicals & Pharmaceuticals, starting with acquiring a controlling stake for approximately ₹11,917 Cr, followed by a merger. This transaction did not impact current quarter's financials. Strong performance was observed across India (+11%), US (+19%), and Brazil (+11%).